Hoshino et al., 2004 - Google Patents
Applications of T-lymphoma labeled with fluorescent quantum dots to cell tracing markers in mouse bodyHoshino et al., 2004
- Document ID
- 3831290532337352463
- Author
- Hoshino A
- Hanaki K
- Suzuki K
- Yamamoto K
- Publication year
- Publication venue
- Biochemical and biophysical research communications
External Links
Snippet
Photoluminescent semiconductor quantum dots (QDs) are novel nanometer-size probes that have found bioimaging. Here we imaged a cell line of mouse lymphocytes. QDs were actively taken into the target cells by endocytotic pathways. The fluorescence of QDs held in …
- 239000002096 quantum dot 0 title abstract description 138
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0058—Antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
- A61K49/0067—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle quantum dots, fluorescent nanocrystals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hoshino et al. | Applications of T-lymphoma labeled with fluorescent quantum dots to cell tracing markers in mouse body | |
| Sukhanova et al. | Biocompatible fluorescent nanocrystals for immunolabeling of membrane proteins and cells | |
| Michalet et al. | Quantum dots for live cells, in vivo imaging, and diagnostics | |
| US8889414B2 (en) | Semiconductor nanocrystal-based phagokinetic tracking | |
| Alivisatos et al. | Quantum dots as cellular probes | |
| Fu et al. | Semiconductor nanocrystals for biological imaging | |
| Rizvi et al. | Semiconductor quantum dots as fluorescent probes for in vitro and in vivo bio-molecular and cellular imaging | |
| Byers et al. | Quantum dots brighten biological imaging | |
| Arya et al. | Quantum dots in bio-imaging: revolution by the small | |
| Bonilla et al. | Applications of quantum dots in food science and biology | |
| Smith et al. | Chemical analysis and cellular imaging with quantum dots | |
| Weng et al. | Luminescent quantum dots: a very attractive and promising tool in biomedicine | |
| Breus et al. | Zwitterionic biocompatible quantum dots for wide pH stability and weak nonspecific binding to cells | |
| Chen et al. | The biocompatibility of quantum dot probes used for the targeted imaging of hepatocellular carcinoma metastasis | |
| Parak et al. | Cell motility and metastatic potential studies based on quantum dot imaging of phagokinetic tracks | |
| Stsiapura et al. | Functionalized nanocrystal-tagged fluorescent polymer beads: synthesis, physicochemical characterization, and immunolabeling application | |
| Liu et al. | Engineering monovalent quantum dot− antibody bioconjugates with a hybrid gel system | |
| Feugang et al. | Self-illuminating quantum dots for non-invasive bioluminescence imaging of mammalian gametes | |
| US20080063720A1 (en) | Delivery System | |
| Dey et al. | Quantum dot: Novel carrier for drug delivery | |
| Hotz | Applications of quantum dots in biology: an overview | |
| Vashist et al. | Review of quantum dot technologies for cancer detection and treatment | |
| Yoo et al. | Intracellular imaging of targeted proteins labeled with quantum dots | |
| Xu et al. | Labeling cytosolic targets in live cells with blinking probes | |
| JPWO2019221062A1 (en) | Drug evaluation method |